ArticleClinicoEconomics and outcomes research : CEOR2014

Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years.

Andreas Karabis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.